News

Launched back in 2005, the European Researchers' Night has become an annual event that is celebrated across Europe on September 29.

Angelini Pharma has been awarded the prestigious Best in Media Communication 2022 (BIC) certification for the second year in a row. This recognition comes after a rigorous audit process conducted by Eikon Strategic Consulting.

Today, the report of the project “Developing trust and effective care for people with schizophrenia” by Gamian Europe, in collaboration with the European Psychiatric Association and with the support of Angelini Pharma, has been released.

In the light of what has been done so far and considering the evolution of the socio-economic and environmental context, Angelini Pharma starts a European dissemination roadmap of Headway’s key takeway.

Purple Day has been held annually around the world on March 26: tens of thousands of people celebrate this day by wearing something purple and taking part in initiatives on epilepsy.

To mark International Women’s Day, Angelini Pharma is once again at the side of the IBE, to support “Women and Epilepsy”, an awareness project to eliminate the stigma against women with epilepsy.

The terrible earthquake that has claimed tens of thousands of lives in Turkey and Syria is a tragedy that cannot leave us indifferent. We at Angelini Pharma feel the need and responsibility to act concretely.

Today, on the occasion of the International Epilepsy Day, Angelini Pharma amplifies IBE’s raising awareness commitment by sharing videos of steps taken and donated to the campaign.

His arrival ushers us into a new chapter in our history, into a new synthesis of tradition and specialised innovation, at a crucial time for health.

The World Cancer Day (WCD) supports cancer awareness, education, and action to promote treatment, prevention, and care for all patients.